Sweeteners

Added sugar accelerates biological aging; "diet" sweeteners are not biologically inert; sugar alcohols carry a real cardiovascular signal. Fructose is the active half of the molecule — it's what makes liquid sugar metabolically distinctive, but the same fructose in whole fruit is metabolised differently because the matrix slows delivery to the liver. The cleanest replacements for routine use are monk fruit and allulose, with small amounts of real honey as an occasional option.

For most healthy adults, the dominant lever is removing the largest sources of free sugar — sugar-sweetened beverages and 100% fruit juice first — rather than swapping them for engineered substitutes. Most non-nutritive sweeteners are better than the full-sugar versions they replace but worse than water, coffee, or unsweetened tea over a lifetime. Two underused levers sit alongside cutting sugar itself: adequate hydration and lower sodium suppress the body's endogenous fructose synthesis, and pre/post-meal physical activity routes any fructose you do eat into glycogen rather than liver fat.

What the evidence says

Strong:

Sugar-sweetened beverages raise CVD, type 2 diabetes, and all-cause mortality in a dose-response pattern. See foods to limit or avoid.
Added sugar at typical Western intakes (~60 g/day vs. the FDA's <50 g/day recommendation) accelerates epigenetic age measured by second-generation clocks (GrimAge2, DunedinPACE).
Fructose from SSBs and 100% fruit juice drives hepatic de novo lipogenesis, hypertriglyceridemia, and MASLD/NAFLD in controlled feeding trials; the same fructose in whole fruit does not, because the matrix changes the rate of absorption^[1].
The 2025–2030 US Dietary Guidelines for Americans dropped the previous 10%-of-calories ceiling on added sugars in favour of "no amount … is recommended or considered part of a healthy diet," with a pragmatic ≤10 g per single meal cap^[2].

Moderate:

Non-nutritive sweeteners (aspartame, sucralose, saccharin, ace-K) do not produce sustained weight loss in long-term trials and associate with stroke and dementia in cohort data, with WHO 2023 issuing a conditional recommendation against use for weight control^[3].
Erythritol and xylitol — the two dominant "keto" sugar alcohols — associate with major adverse cardiovascular events at the population level and enhance platelet reactivity in mechanistic experiments^[4]^[5].
Allulose lowers postprandial glucose and insulin in human RCTs by stimulating endogenous GLP-1 release.
Honey (raw, ~40 g/day for 8 weeks) modestly improves fasting glucose, LDL-C, and HDL-C in pooled RCTs.
High-salt diets activate the polyol pathway (aldose reductase → sorbitol → endogenous fructose) and drive hepatic fat storage and leptin resistance independent of dietary sugar; adequate hydration largely abrogates this^[6].
Exercise that depletes hepatic glycogen abrogates the lipogenic and hypertriglyceridemic effects of high-fructose meals in controlled crossover trials^[7].
Highest tertile of added-fructose intake associates with a ~3× relative risk of short telomeres versus the lowest tertile in healthy adults^[8].

Weak / preliminary:

"Catalytic" doses of fructose (~10 g per meal, ≤36 g/day) used in isocaloric exchange for other carbs modestly improve HbA1c via glucokinase translocation — small effect, real mechanism^[9].
Intergenerational microbiome and gene-expression effects of sweeteners — mouse data only.
Allulose, monk fruit, and honey-polyphenol activation of AMPK / SIRT1 longevity pathways — preclinical.
Manuka honey methyl syringate as a systemic anti-inflammatory longevity therapeutic — in vitro and animal.

Caution:

Erythritol and xylitol used as routine bulk sweeteners in adults with established cardiovascular disease, prior stroke, atrial fibrillation, or otherwise elevated thrombotic risk.

Added sugar accelerates biological aging

The clearest single finding to emerge in the last few years is that added free sugars accelerate the epigenetic clocks now used as the standard biomarker of biological age. A 2024 ^[10] of midlife Black and White women in the NIMHD Social Epigenomics cohort found a dose-response association between daily added-sugar intake and acceleration of the GrimAge2 and DunedinPACE clocks. Mean intake was ~61 g/day, above the FDA's 50 g/day ceiling.

The mechanism is not exotic. Chronically elevated postprandial glucose and fructose drive de novo lipogenesis, advanced glycation end-products, and low-grade inflammation, all of which alter DNA-methylation patterns toward the senescent profile the clocks read off. NHANES analyses of leukocyte telomere length point in the same direction: regular sugar-sweetened soda consumption associates with shorter telomeres in otherwise-healthy adults^[11].

The headline number from the JAMA Network Open paper — "every gram of added sugar nudges the clock forward" — is true at the population level but should be read as a monotonic dose-response, not a per-gram action threshold. For practical purposes, the WHO/AHA targets of <25 g/day added sugar (women) or <10% of total calories capture most of the benefit available from the lever.

This is the strongest evidence-based reason to remove sugar-sweetened beverages first: they are the largest single source of added sugar in most diets, and the cohort data linking them to mortality is older and more consistent than any data on the substitutes.

Fructose is the signal, not the calorie

Glucose and fructose both carry 4 kcal/g, but the liver doesn't treat them as interchangeable. Glucose has a built-in brake: when liver cells already have plenty of energy, an upstream enzyme throttles further glucose breakdown. Fructose has no equivalent brake. The enzyme that handles it processes fructose as fast as it arrives — regardless of whether the cell needs the energy^[12].

What happens next is what makes added sugar biologically distinctive. Rapid fructose processing transiently drains the liver cell's energy currency (ATP) and generates uric acid as a byproduct inside the cell. The uric acid then enters mitochondria — the cell's energy-producing furnaces — creates oxidative stress, and partially jams two key energy pathways: the citric-acid cycle (the central hub of food-to-ATP conversion) and the fat-burning machinery. With those routes throttled, the carbons that came in as fructose can't be oxidized efficiently and are shunted instead into building new fat. Some of the fat accumulates inside the liver itself — the molecular origin of MASLD/NAFLD, also known as fatty liver disease — and the rest is exported into the bloodstream as triglyceride-rich particles^[13]^[14].

This is also the cleanest mechanistic answer to a question the epigenetic-age data leaves open: why does added sugar accelerate biological aging at intakes that aren't strictly hypercaloric? Because the same uric-acid-and-fat-synthesis pathway nudges all three of the cell's master nutrient sensors in the wrong direction at once — depressing SIRT1, blunting AMPK, and hyperactivating mTORC1. Those three sensors together govern cellular cleanup (autophagy) and mitochondrial quality control^[15]. Whether this is enough to move the GrimAge2/DunedinPACE epigenetic clocks in any individual is dose-dependent, but the mechanistic pieces line up with the population-level methylation findings.

The survival switch (and why this pathway exists at all)

About 15 million years ago, our ape ancestors lost a working copy of uricase, the enzyme that breaks down uric acid. That mutation amplified the uric-acid response to dietary fructose. The plausible reason — formalized as the fructose survival hypothesis — is that this response was an adaptive pre-winter programme: blunt the satiety signal so the animal keeps eating, drive foraging, and store seasonal fructose as belly fat and liver glycogen before scarcity arrived^[16]. The system was designed to run for two months a year. In a year-round ultra-processed-food environment it runs continuously, which is the textbook description of metabolic syndrome.

The catalytic dose: small fructose is not the same as a lot of fructose

Toxicity is dose- and rate-dependent. Trace fructose — defined in the literature as ≤10 g per meal or ≤36 g per day — does the opposite of a large bolus. A small dose actually helps the liver clear glucose: it pulls a key glucose-handling enzyme (glucokinase) free of the protein that normally holds it in the cell nucleus, releasing it into the cell body where it can work on circulating sugar. A meta-analysis of controlled feeding trials shows that catalytic-dose fructose, swapped one-for-one for other carbohydrates at the same calorie count, modestly lowers HbA1c (the standard three-month blood-sugar marker) without a weight, lipid, or uric-acid penalty^[17]. The clinical effect is small but the biochemistry explains why fructose from whole vegetables and berries is not just tolerated but mildly useful.

Endogenous fructose: the high-salt and dehydration connection

Dietary intake isn't the only fructose source. The body can manufacture fructose internally from glucose via a two-step conversion called the polyol pathway, driven not only by high blood sugar but also by an overly concentrated bloodstream — from high salt intake or dehydration. The body reads a concentrated bloodstream as impending water scarcity, switches the pathway on, converts circulating glucose into fructose, and stores the carbons as fat. The logic is that burning fat later releases a small amount of water (so-called "metabolic water"), so building a fat reserve is a hedge against drought. The thirst hormone vasopressin reinforces the same fat-building programme when it acts on the liver^[18]^[19].

The clinical reading: high-salt ultra-processed diets can drive insulin resistance, fatty liver, and weight gain even with little dietary sugar, because the liver is manufacturing the fructose internally. Two correctives — reducing sodium and drinking enough water to keep urine pale — are cheap, well-tolerated, and act directly on the same pathway as cutting added sugar. This is one of the more practically useful findings of the last few years and is under-represented in mainstream sugar advice.

Exercise abrogates fructose toxicity

The fat-building harm of a high-fructose meal depends on the liver's glycogen tank being already full. In a glycogen-depleted state — after rigorous exercise — the carbons from fructose are preferentially routed into refilling the glycogen tank rather than dumped into new fat. A controlled crossover trial in healthy young adults found that a diet with 30% of energy from fructose — which produced severe hypertriglyceridemia (elevated blood triglycerides) and a measurable rise in liver fat synthesis in sedentary controls — produced neither effect when the same diet was paired with moderate aerobic exercise^[20]. Exercise also acutely activates AMPK, partially reversing the suppression of that same longevity sensor by fructose.

The endurance-athlete corollary: during prolonged exercise, fructose is an ergogenic aid, not a toxin. The gut's main glucose absorber maxes out at around 60 g/h; co-ingesting glucose and fructose (typically in a 2:1 ratio) recruits a separate, dedicated fructose absorber to bypass that bottleneck and support carbohydrate-oxidation rates of 90–108 g/h without GI distress^[21]. Post-exercise, glucose + fructose refills both muscle and liver glycogen faster than glucose alone. None of this contradicts the rest of the section — it's the same biology read in a different energetic state.

Telomeres

A cross-sectional study of healthy adults found the highest third of added-fructose intake associated with roughly 3× the relative risk of short white-blood-cell telomeres versus the lowest third, after adjusting for total energy and standard confounders^[22]. One study, observational, but mechanistically consistent: chronic fructose generates advanced glycation end-products — sugar-damaged proteins that build up in tissues — which feed the same chronic low-grade inflammation ("inflammaging") the second-generation epigenetic clocks pick up.

The food matrix: whole fruit, juice, smoothies

The fructose in an apple is the same molecule as the fructose in a soft drink. The metabolic outcome is different because the matrix changes the rate and route of delivery.

Intact plant cell walls — cellulose, pectin, lignin — slow gastric emptying and delay enzymatic release of fructose in the small intestine. Portal-vein delivery is gradual, the hepatic ATP pool is not crashed, AMP deaminase is not triggered, and the lipogenic cascade stays off. Soluble fibres and polyphenols that reach the colon are fermented by Bifidobacteria and Faecalibacterium prausnitzii into short-chain fatty acids (butyrate, propionate, acetate) that act as endogenous HDAC inhibitors and reinforce gut-barrier integrity. Pooled cohort data consistently show whole-fruit consumption inversely associated with cardiovascular and all-cause mortality, in the same studies where free-sugar intake is associated with elevated risk^[23]^[24].

100% fruit juice strips most of the fibre matrix and delivers fructose in liquid form. On glycemic and lipogenic endpoints it behaves much closer to SSBs than to whole fruit at equivalent dose, especially in children^[25]. Smoothies, which pulverize but retain the fibre in suspension, behave closer to whole fruit^[26]. For practical purposes: blended ≠ juiced.

A rough hierarchy by fructose-to-fibre ratio per typical serving (USDA composition; values vary by variety):

Food	Fructose	Fibre	Notes
Avocado (1 medium)	<1 g	~7 g	Trace fructose, high satiety fibre
Raspberries (1 cup)	~3 g	~8 g	Excellent prebiotic pectin
Blackberries (1 cup)	~3.5 g	~5 g	Low glycemic impact
Strawberries (1 cup)	~3.8 g	~3 g	High polyphenol content
Apple (1 medium)	~9.5 g	~4.4 g	Pectin buffers the load
Watermelon (large wedge)	~11 g	<0.5 g	Low fibre, fast absorption
Grapes (1 cup)	~12 g	~1.4 g	Readily absorbable
Mango (½ medium)	~16 g	~1.5 g	High relative load
Dried figs (1 cup)	~23 g	~12 g	Treat as dessert; dehydration concentrates sugar

The practical reading is not "avoid mangoes" but "the fructose-to-fibre ratio of a food is a better guide to its metabolic impact than its total sugar number." For meal-sequencing and timing context, see glycemic index and postprandial glucose.

Non-nutritive sweeteners are not inert

Aspartame, sucralose, saccharin, and acesulfame-K were originally licensed on the assumption that anything that didn't deliver calories couldn't matter metabolically. That assumption has not held up.

The WHO 2023 guideline. A systematic review found no long-term body-fat benefit from non-sugar sweeteners and signals of increased risk for type 2 diabetes, cardiovascular disease, and all-cause mortality with habitual use. The certainty rating in the underlying evidence is low — the conditional recommendation against use reflects weighing potential harm against the absence of demonstrated benefit, not strong direct evidence of damage^[27].

Cohort signals. The Framingham Offspring Study found daily artificially-sweetened soft-drink intake associated with roughly threefold higher rates of incident ischemic stroke and Alzheimer's dementia over a decade of follow-up^[28]. The 2024 ELSA-Brasil cohort (n=12,772, ~8 years follow-up) reported that the highest intake of low- and no-calorie sweeteners associated with measurably faster declines in global cognition, memory, and verbal fluency — equivalent to ~1.3 years of accelerated cognitive aging across the study period^[29]. Both are observational; reverse causality (people switching to diet drinks because of pre-existing metabolic disease) is plausible and partially controllable but not eliminable.

Microbiome and glucose tolerance. A 2022 Cell RCT (Suez et al.) gave non-diabetic adults daily doses of saccharin or sucralose for two weeks and found measurable shifts in gut-microbiome composition and glycemic response — with the size of the effect varying by individual baseline microbiome. This is the cleanest causal evidence that NNS are biologically active, but the long-term clinical significance is unclear.

Intergenerational data. A 2026 Frontiers in Nutrition mouse study reported that parental sucralose and stevia consumption produced microbiome and gene-expression changes in offspring out to F2. Interesting but mouse-only; transgenerational extrapolation to humans is speculative, and rodent coprophagy complicates microbiome-mediated inheritance specifically.

Practical reading. Non-nutritive sweeteners are better than the sugar versions they replace if the alternative is a daily SSB, and they're useful as a transitional tool when tapering off sugar. They are not a long-term default. Water, coffee, tea, and sparkling water are.

Sugar alcohols: the polyol cardiovascular signal

The most consequential dietary-sweetener finding of the last several years concerns erythritol and xylitol — the two polyols that dominate "keto," "diabetic," and sugar-free product categories.

Erythritol. A 2023 Nature Medicine paper from the Cleveland Clinic group analyzed a discovery cohort plus US (n=2,149) and European (n=833) replication cohorts and found that plasma erythritol in the highest quartile predicted three-year MACE (composite of cardiovascular death, MI, and stroke) with adjusted hazard ratios around 2.0^[30]. Mechanistically, the same group showed erythritol enhances platelet reactivity at physiologically achievable plasma concentrations and that a single sweetener-typical dose (~30 g) raises plasma levels above the platelet-activation threshold for >48 hours.

One important caveat the headlines often miss. Circulating erythritol is partly endogenous: the body produces it from glucose via the pentose phosphate pathway, and production rises in metabolic stress. The cohort data therefore mixes a biomarker effect (erythritol as a marker of underlying cardiometabolic disease) with a direct-toxicity effect. The mechanistic platelet work is what makes the dietary-intake interpretation plausible — and is the load-bearing piece for the recommendation, not the hazard ratio alone.

Xylitol. A 2024 European Heart Journal paper from the same group ran the same analysis and found ~1.6× higher three-year MACE risk in the highest tertile of plasma xylitol, with mechanistic platelet-reactivity data again confirming biological plausibility^[31].

Sorbitol is less studied, but the same metabolic family. Maltitol and isomalt have not generated comparable signals.

Practical: treat erythritol- and xylitol-sweetened products (keto baking goods, sugar-free candies, low-carb protein bars) as occasional, not staples — particularly for adults with established cardiovascular disease, prior stroke, atrial fibrillation, or those on antiplatelet therapy. The xylitol gum used in dentistry is small-dose and doesn't reach the plasma levels that drive the platelet effect.

Stevia and monk fruit

Both are plant-derived, zero-calorie high-intensity sweeteners. They are reasonable replacements for synthetic NNS when sweetness is wanted without calories, with monk fruit currently the cleaner profile.

Stevia (steviol glycosides, ~200–300× sweeter than sucrose). In short-term human studies, no consistent harm signal on glucose, blood pressure, or weight; some animal data suggests mild antioxidant and anti-inflammatory effects. Two qualifications: it has been shown to interfere with bacterial quorum sensing, raising the question of microbiome effects at high chronic intake; and the 2026 Frontiers in Nutrition mouse study (cited above) included stevia and found milder but nonzero intergenerational signals. For the average adult, stevia in modest amounts is fine; it should not be assumed perfectly inert.

Monk fruit (mogrosides, ~150–250× sweeter than sucrose). Mogrosides pass intact through the upper GI tract; colonic bacteria cleave the glucose moiety and use the rest as a substrate, with possible prebiotic effects. In vitro and animal data suggest mogroside V has antioxidant activity. There is no human cardiovascular, microbiome, or cognitive harm signal of meaningful size to date — though the human evidence base is thinner than for sucralose or aspartame, and "no signal yet" is not the same as "demonstrated safe at high lifetime intake."

For the healthy adult choosing between high-intensity sweeteners, monk fruit is currently the most defensible default.

Rare sugars: allulose and tagatose

Rare sugars are naturally occurring monosaccharides whose structural variations change how the human body handles them. The two with meaningful human data are D-allulose and D-tagatose. Both are technically caloric (~0.4 kcal/g for allulose, ~1.5 kcal/g for tagatose) but mostly not metabolized for energy.

Allulose. Roughly 70% is absorbed in the small intestine and excreted unchanged in urine; the remaining 30% reaches the colon and resists fermentation. In human RCTs, pre-meal allulose lowers postprandial glucose and insulin, particularly with carbohydrate-heavy meals. The mechanism is endogenous GLP-1 release: allulose triggers GLP-1 secretion in the gut, activating vagal afferents that signal satiety to the brainstem and hypothalamus^[32]. In animal models, GLP-1-receptor knockout or vagotomy abolishes the anti-obesity and glucose-lowering effects, confirming the GLP-1–vagal axis is doing the work.

A practical caveat: allulose is not a substitute for prescription GLP-1 receptor agonists. The endogenous GLP-1 signal it produces is small in absolute terms compared to a semaglutide dose. Frame it as a useful sugar substitute that doesn't raise blood glucose, not as a "natural Ozempic."

The longevity-pathway claims sometimes attached to allulose — AMPK and SIRT1 activation in adipocytes, C. elegans lifespan extension — are real preclinical findings but should not be over-interpreted; they are not a basis for human longevity recommendations.

Tagatose has FDA GRAS status and a low glycemic index. Small trials show modest HbA1c improvements and lipid changes; no significant safety signals.

Practical. For an adult who wants a sugar substitute that bakes and tastes close to sucrose without raising glucose, allulose is currently the best-evidenced option. The gating factors are cost and availability; GI tolerability (loose stools, gas) is the most common limiting issue at >0.5 g/kg per single dose.

Honey

Honey is ~80% simple sugars by mass, but the matrix matters. Raw, unfiltered honey contains over 200 bioactive compounds — flavonoids, phenolic acids, glucose oxidase, catalase. Pasteurized, ultrafiltered supermarket honey has most of these stripped and behaves nutritionally closer to high-fructose corn syrup.

A 2023 University of Toronto systematic review and meta-analysis pooled 18 RCTs (>1,000 participants, median dose ~40 g/day for ~8 weeks) and found honey consumption associated with modest reductions in fasting glucose, ALT, total and LDL cholesterol, and triglycerides, alongside small HDL-C increases — counterintuitive given the sugar content, attributed to the polyphenol matrix. Effect sizes are clinically modest and the trials are mostly short.

Manuka honey (high-methylglyoxal honey from Leptospermum scoparium) has well-established topical antibacterial activity. The systemic anti-inflammatory and SIRT1-activation claims are based on in vitro neutrophil work and small animal studies — interesting, not load-bearing.

Practical reading. A tablespoon (~20 g) of raw honey in tea or yogurt as an occasional sweetener is fine and probably modestly better than refined sugar in equivalent amount, because of the polyphenol content. It is still ~80% sugar; volume matters more than provenance.

Practical guidance

Remove sugar-sweetened beverages and 100% fruit juice first. Largest single dietary lever for free-fructose exposure; the cohort harm data for liquid sugar is the strongest in the entire literature.
Default beverages: water, coffee, tea, sparkling water. Unsweetened. More impactful than choosing between non-nutritive alternatives. Adequate hydration also directly suppresses the polyol pathway that generates endogenous fructose from glucose.
Keep added sugar under ~10 g per meal. The 2025–2030 US dietary guidelines stopped specifying a daily allowance and instead set a per-meal ceiling, on the rationale that it's the bolus — not the daily total — that overwhelms hepatic fructolysis and triggers the lipogenic cascade. Spreading 25 g across the day is metabolically very different from a single 25-g hit.
Eat fructose with its matrix. Whole fruit > smoothie ≫ juice ≫ soft drink at the same gram dose. Favour berries, avocado, and other high-fibre/low-fructose fruits as the default; mango, grapes, dried fruit as occasional. The fructose-to-fibre ratio table above is a more useful guide than total sugar.
Lower dietary sodium and stay hydrated. High-salt diets and dehydration activate aldose reductase and let the body synthesize fructose internally from glucose; this drives metabolic syndrome even with little dietary sugar. Pale urine is a usable proxy.
Move before (or after) carbohydrate-heavy meals. Glycogen-depleted muscle and liver route fructose into glycogen resynthesis rather than lipogenesis; aerobic exercise abrogates the triglyceride and DNL response to high-fructose meals in controlled trials. Endurance athletes can use a 2:1 glucose:fructose mix during prolonged sessions to bypass the SGLT1 ceiling.
Front-load carbohydrates earlier in the day. Late-evening consumption hits the liver when peripheral circadian clocks are misaligned and insulin sensitivity is lower; late eaters show poorer glucose tolerance and higher MASLD risk in isocaloric studies.
For zero-calorie sweetness when wanted: monk fruit > stevia > NNS. Use as a tool, not a daily default.
For sugar substitutes in baking: allulose if cost permits; otherwise small amounts of regular sugar in an otherwise Mediterranean-pattern diet.
Avoid erythritol and xylitol as routine bulk sweeteners if you have established cardiovascular disease, atrial fibrillation, prior stroke, or are on antiplatelet therapy. The xylitol gum used dentally is too small-dose to matter.
Honey: occasional, raw if possible, ~1 tablespoon. Treat as a sugar with extras, not a health food.
Don't switch to diet sodas as a long-term strategy — short-term taper from full-sugar SSBs is a reasonable use, but the multi-year cohort data on cognitive and vascular endpoints is worth taking seriously.

What's overrated

"Allulose is a longevity mimetic." Based on AMPK/SIRT1 activation in adipocytes and C. elegans lifespan extension. Real preclinically; not a human longevity claim.
"Manuka honey is anti-aging." In vitro neutrophil and SIRT1 work; useful for wound care, not a systemic intervention.
"Stevia is biologically inert because it's natural." It alters bacterial quorum sensing and showed mild intergenerational signals in mice. Probably fine; not zero.
"Diet sodas are safe replacements." Better than SSBs in the short term; the long-term cohort data on stroke and dementia is hard to dismiss.
Transgenerational sweetener inheritance from mouse studies as a near-term human concern. Worth tracking; not currently a basis for recommendations.
"Fructose is poison." True for a 50-gram liquid bolus in a sedentary, glycogen-replete, dehydrated person. Not true for the 3 g of fructose in a cup of berries eaten after a workout. Dose, matrix, hydration, and energy state determine the outcome; the molecule alone does not.
"Whole fruit causes diabetes." Whole fruit consistently associates with lower cardiovascular and all-cause mortality in the same large cohorts where free sugars associate with higher mortality. The matrix is doing the work.